Wordt geladen...
Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies
Despite its good initial response and significant survival benefit in patients with castration-resistant prostate cancer (CRPC), taxane therapy inevitably encounters drug resistance in all patients. Deep understandings of taxane resistant mechanisms can significantly facilitate the development of ne...
Bewaard in:
| Gepubliceerd in: | Acta Pharm Sin B |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089846/ https://ncbi.nlm.nih.gov/pubmed/30109177 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2018.04.007 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|